Table 2.
Authors | Interventions | Animal Models | Results | |||
---|---|---|---|---|---|---|
Zille et al. 2017 | Chemical inhibitors implicated in all known cell death pathways | Cultured neurons exposed to hemoglobin or hemin | Experimental intracerebral hemorrhage shares features of ferroptotic and necroptotic, but not caspase-dependent apoptosis or autophagy | |||
Shen et al. 2017 | Nec-1 Mutation of serine kinase phosphorylation site of RIP1 |
ICH in rats | Inhibition of necroptosis | |||
Qu et al. 2017 | Inhibition of the RIP3-MLKL or RIP3-CaMKIIdelta interaction | OGD/zVAD in oligodendrocytes HI in postnatal day 6 (P6) rats |
Disrupted development of myelin was attenuated | |||
Xu et al. 2017 | Necroptosis, autophagy, and apoptosis inhibitor | Global cerebral I/R injury model in rats | Mitochondria are involved in the execution of programmed necrosis, and AIF is the mediating molecule | |||
Qu et al. 2016 | Inhibition of MLKL | OGD/zVAD in cortical neurons HI in rats |
Attenuated neuronal death induced by OGD/zVAD and brain damage induced by HI | |||
LaRocca et al. 2016 | nec-1s Treatment with high levels of glucose |
HI in mice | Resulted in increased infarct size, which can be prevented by nec-1s | |||
Yin et al. 2015 | Nec-1 pretreatment | Global cerebral I/R injury | Nec-1 pretreatment prevented hippocampal CA1 neuronal death and I/R induced changes in RIP3 | |||
Xuan et al. 2015 | A Water-Soluble Extract from the Culture Medium of Ganoderma lucidum Mycelia | HI in type 2 diabetic KKAy mice | Reduced H/I-induced neurological deficits and brain infarction volume and suppressed superoxide production, neuronal cell death, and vacuolation in the ischemic penumbra | |||
Wang et al. 2015 | extracellular protons | MCAO in mice | Acid stimulation recruits RIP1 to the ASIC1a C-terminus, causing RIP1 phosphorylation and subsequent neuronal death | |||
Su et al. 2015 | Nec-1 pretreatment | ICH in mice | Nec-1 pretreatment improved neurological function, attenuated brain edema, reduced RIP1-RIP3 interaction and PI positive cell death and inhibited microglia activation | |||
Askalan et al. 2015 | For 90min in the mild-moderate HI or 180min in the severe HI. | HI in rats | Necroptosis was significantly higher in the peri-infarct of the severe HI lesion compared to the moderate HI lesion. In males, but not in females, apoptosis was higher in moderate compared to severe HI | |||
Vieira et al. 2014 | RIP3 KD or overexpression | OGD in primary cultures of hippocampal neurons | RIP3 KD abrogated the component of OGD-induced necrotic neuronal death while RIP3 overexpression exacerbated neuronal death following OGD | |||
Liu et al. 2014 | RIP3 deficiency in mice KD of CYLD or RIP1 or RIP3 or MLKL in HT-22 cells |
Intracerebroventricular injection of TNF-alpha in mice TNF-alpha-induced toxicity of hippocampal neurons in HT-22 cells |
RIP3 deficiency attenuates TNF-alpha-initiated loss of hippocampal neurons The cell death is suppressed by KD of CYLD or RIP1 or RIP3 or MLKL |
|||
King et al. 2014 | Nec-1 | ICH in mice | Nec-1 significantly reduced hematoma volume and BBB opening, attenuated edema development, and improved neurobehavioral outcomes | |||
Chang et al. 2014 | Nec-1 | ICH in mice | Nec-1 suppressed apoptosis, autophagy, and necroptosis to exert these neuroprotective effects after ICH | |||
Dai et al. 2013 | Curcumin | Iron induced neurotoxicity in primary cortical neurons | Curcumin attenuated necroptosis in a dose-dependent manner and decreased expression of receptor interacting protein 1 in a dose- and time-dependent manner | |||
Zhu et al. 2012 | RIP3 deficiency | ICH in mice | Mice deficient in RIP3 had 50% less PI+ cells at 24 h. Permeable cells remained in the brain for at least 24 h with <10% spontaneous resealing | |||
Chen et al. 2012 | GA | OGD/zVAD in cultured primary neurons |
GA protected against neuronal injury and decreased RIP1 protein level in a time- and concentration-dependent manner | |||
Authors | Interventions | Animal Models | Results | |||
Chavez-Valdez et al. 2012 | Nec-1 immediately after HI | Neonatal HI in mice | Nec-1 immediately after HI, is strongly mitoprotective and prevents secondary energy failure by blocking early NO* accumulation, glutathione oxidation and attenuating mitochondrial dysfunction | |||
Northington et al. 2011 | Nec-1 | Neonatal HI in mice | Necrostatin treatment attenuated necrotic cell death, HI-induced oxidative damage and markers of inflammation | |||
Xu et al. 2010 | Nec-1 HNG |
OGD in cultured mouse primary cortical neurons MCAO in mice |
Nec-1 or HNG alone had protective effects on OGD-induced cell death. Combined treatment with Nec-1 and HNG resulted in more neuroprotection than Nec-1 or HNG alone | |||
Xu et al. 2010 | PJ34 Nec-1 |
Glutamate-induced necroptosis in HT-22 cells |
Nec-1 is not a direct PARP inhibitor and that its signaling target is located upstream of PARP | |||
Li et al. 2008 | Nec-1 | NMDA-induced excitotoxicity in rat's cultured cortical neurons | Nec-1 inhibited NMDA-induced decrease of cell viability, attenuated NMDA-induced leakage of LDH and suppressed NMDA-induced elevation of intracellular Ca2+ | |||
Degterev et al. 2005 | Nec-1 | Delayed mouse ischemic brain injury | A specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, blocks a critical step in necroptosis |
Abbreviations: RIP1: Receptor-interacting protein 1; RIP3: Receptor-interacting protein 3; MLKL: Mixed lineage kinase domain-like; Nec-1: Necrostatin-1, RIP1 inhibitor; Nec-1s: Nec-1 derivatives; KD: knock-down; I/R: Ischemia/reperfusion; HNG: Gly(14)-humanin, apoptosis inhibitor; GA: Geldanamycin; PJ34: a potent and specific inhibitor of poly(ADP-ribose)-polymerase (PARP); PI: Propidium iodide; BBB: Blood-brain barrier; ICH: Collagenase-induced intracerebral hemorrhage; OGD/zVAD: Oxygen-glucose deprivation plus caspase inhibitor zVAD treatment; OGD: Oxygen-glucose deprivation; HI: Hypoxia-ischemia; MCAO: Middle cerebral artery occlusion; ASIC1a: Acid-sensing ion channel 1; ICH: Intracerebral hemorrhage; LDH: Lactate dehydrogenase; NMDA: N-methyl-D-aspartic acid.